UY29779A1 - Nitrooxi derivados de esteroides - Google Patents

Nitrooxi derivados de esteroides

Info

Publication number
UY29779A1
UY29779A1 UY29779A UY29779A UY29779A1 UY 29779 A1 UY29779 A1 UY 29779A1 UY 29779 A UY29779 A UY 29779A UY 29779 A UY29779 A UY 29779A UY 29779 A1 UY29779 A1 UY 29779A1
Authority
UY
Uruguay
Prior art keywords
nitrooxi
steroids
derived
nitrooxy
new
Prior art date
Application number
UY29779A
Other languages
English (en)
Spanish (es)
Inventor
Francesca Benedini
Ennio Onigini
Daniel Palop
Marta Princep
Original Assignee
Ferrer Int
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37450883&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29779(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int, Nicox Sa filed Critical Ferrer Int
Publication of UY29779A1 publication Critical patent/UY29779A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
UY29779A 2005-09-02 2006-09-01 Nitrooxi derivados de esteroides UY29779A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05019155 2005-09-02

Publications (1)

Publication Number Publication Date
UY29779A1 true UY29779A1 (es) 2006-12-29

Family

ID=37450883

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29779A UY29779A1 (es) 2005-09-02 2006-09-01 Nitrooxi derivados de esteroides

Country Status (19)

Country Link
US (5) US20080221073A1 (https=)
EP (1) EP1940863B1 (https=)
JP (1) JP5216589B2 (https=)
KR (1) KR20080039442A (https=)
CN (2) CN101300265A (https=)
AR (1) AR056868A1 (https=)
AU (1) AU2006286838C1 (https=)
BR (1) BRPI0614967A2 (https=)
CA (1) CA2621117A1 (https=)
ES (1) ES2393363T3 (https=)
IL (2) IL189337A0 (https=)
NO (1) NO20081614L (https=)
NZ (1) NZ566128A (https=)
RU (1) RU2415864C2 (https=)
SG (1) SG158916A1 (https=)
TW (1) TW200801031A (https=)
UY (1) UY29779A1 (https=)
WO (1) WO2007025632A2 (https=)
ZA (1) ZA200801789B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802726B2 (en) 2006-02-03 2014-08-12 Nicox S.A. Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
BRPI0807078A2 (pt) * 2007-02-05 2014-04-08 Nicox Sa Composto, e, formulação farmacêutica
EP1964550A1 (en) * 2007-03-01 2008-09-03 NicOx S.A. Glucocorticoid-nitrooxyderivative compositions
ES2324007A1 (es) * 2007-10-25 2009-07-28 Ferrer Internacional, S.A. Una forma amorfa de un compuesto antiinflamatorio.
ES2442720T3 (es) * 2008-07-31 2014-02-13 Nicox S.A. Glucocorticoides unidos a ésteres de nitrato por medio de un enlazador aromático en posición 21 y su uso en oftalmología
CN102186873A (zh) * 2008-08-05 2011-09-14 尼科克斯公司 用于治疗视网膜和黄斑疾病的新型释放no的甾类化合物
CN102186874A (zh) * 2008-08-05 2011-09-14 尼科克斯公司 新的释放no的类固醇衍生物
US8062653B2 (en) 2009-02-18 2011-11-22 Bezwada Biomedical, Llc Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
EP2398761A4 (en) * 2009-02-18 2015-11-04 Bezwada Biomedical Llc CONTROLLED RELEASE OF NITRIC OXIDE AND MEDICINES FROM FUNCTIONALIZED MACROMERS AND OLIGOMERS
US9022788B2 (en) * 2009-10-17 2015-05-05 Gregory John Stahler System and method for cardiac defibrillation response simulation in health training mannequin
ES2359708B1 (es) * 2009-11-16 2012-03-30 Ferrer Internacional S.A. Procedimiento de preparación de la (11beta,16alfa)-9-fluoro-11-hidroxi-16,17-[1-metil-etilidenebis(oxi)]-21-[1-oxo-[4-(nitrooximetil)benzoxi]]preña-1,4-dien-3,20-diona.
ES2362894B1 (es) 2009-11-16 2012-05-21 Ferrer Internacional S.A. Procedimiento de preparación del �?cido 4-nitro-oxi-metil-benzoico.
CN110382033B (zh) * 2016-10-14 2022-04-15 范安德尔研究所 用于设计高效力糖皮质激素的结构与机制
AU2021241591A1 (en) 2020-03-24 2022-10-20 Michael W. BURNET Anti-infective and anti-viral compounds and compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56138200A (en) 1980-02-15 1981-10-28 Glaxo Group Ltd Androstane carbothioate compound
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US5985862A (en) * 1996-05-02 1999-11-16 G.D. Searle & Co. Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
IT1285770B1 (it) * 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
IT1311922B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases

Also Published As

Publication number Publication date
US20080221073A1 (en) 2008-09-11
AR056868A1 (es) 2007-10-31
WO2007025632A3 (en) 2007-04-19
US20090264393A1 (en) 2009-10-22
IL189337A0 (en) 2008-06-05
US20090264394A1 (en) 2009-10-22
JP5216589B2 (ja) 2013-06-19
AU2006286838C1 (en) 2013-05-02
US20110294769A1 (en) 2011-12-01
IL216516A0 (en) 2011-12-29
AU2006286838B2 (en) 2012-03-29
EP1940863A2 (en) 2008-07-09
KR20080039442A (ko) 2008-05-07
WO2007025632A2 (en) 2007-03-08
CN102134269A (zh) 2011-07-27
CA2621117A1 (en) 2007-03-08
SG158916A1 (en) 2010-02-26
RU2415864C2 (ru) 2011-04-10
JP2009506994A (ja) 2009-02-19
ES2393363T3 (es) 2012-12-20
ZA200801789B (en) 2008-12-31
RU2008111076A (ru) 2009-10-10
AU2006286838A1 (en) 2007-03-08
EP1940863B1 (en) 2012-09-05
BRPI0614967A2 (pt) 2013-01-01
US20090258849A1 (en) 2009-10-15
TW200801031A (en) 2008-01-01
NZ566128A (en) 2011-03-31
CN101300265A (zh) 2008-11-05
NO20081614L (no) 2008-05-28

Similar Documents

Publication Publication Date Title
UY29779A1 (es) Nitrooxi derivados de esteroides
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
DE50312034D1 (de) Liposomale glucocorticoide
HN1999000124A (es) Derivados de pirazol substituido.
CY1108453T1 (el) Διαδικασια για την παρασκευη επλερενονης
NO20076508L (no) Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav
CO6430467A2 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosméticas o farmacéuticas
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
CL2007002169A1 (es) Compuestos derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso del compuesto para prevenir o tratar la inflamacion, trastornos urologicos, gastrointestina
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
BRPI0517227B8 (pt) comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
SG152257A1 (en) Topical preparation containing ambroxol
ITVA20060041A1 (it) Uso di composti derivati amminotiazolici, di loro composizioni farmaceutiche, nel trattamento di malattie caratterizzate dalla anormale repressione della trascrizione genica, particolarmente il morbo di huntington
CY1112540T1 (el) Αμορφη μορφη της (11βητα,16αλφα)-9-φθορο-11-υδροξυ-16,17-[(μεθυλοαιθυλιδενο)δι(οξυ)]-21-[(4-[(νιτροοξυ)μεθυλο]βενζοϋλ]οξυ]-πρεγνα-1,4-διεν-3,20-διονης
EP1594435A4 (en) INHIBITION OF HIV-1 REPLICATION BY TREATMENT OF THE PROCESSING OF THE VIRAL CAPSID-SPACER PEPTIDE 1 PROTEIN
ECSP003747A (es) Metodo y composiciones para el tratamiento de las enfermedades pulmonares
BR0313589A (pt) Uso de extrato de germe de trigo fermentado como agente antiinflamatório
PA8661701A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
HUP0402624A2 (hu) Vírusgátlás n-dokozanollal
NO20023841L (no) Anvendelse av glukokortikoidreseptorantagonister for forebygging og behandling av sykdommer av reproduksjonssystemet hos menn
AR018313A1 (es) Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo
UY26945A1 (es) Alcanosulfonatos de fenoxifenilo
CY1110192T1 (el) Κρυσταλλικες μορφες ενωσεων μακρολιδων με αντιφλεγμονωδη δραση
NO20064195L (no) Legemiddel for utvortes bruk pa hud og mukosalskade forarsaket av virusinfeksjon